Stay updated on Safety of Tarlatamab in Adults With SCLC Clinical Trial

Sign up to get notified when there's something new on the Safety of Tarlatamab in Adults With SCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety of Tarlatamab in Adults With SCLC Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The site footer now identifies the ClinicalTrials.gov release as v3.7.2 instead of v3.7.1.
    Difference
    0.0%
    Check dated 2026-10-18T13:51:53.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The site footer revision number changed from v3.7.0 to v3.7.1.
    Difference
    0.0%
    Check dated 2026-10-11T15:20:16.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    35 days ago
    Change Detected
    Summary
    The page's revision tag changed from v3.6.6 to v3.7.0, indicating a new build of the site interface. This change does not modify the study record details or data.
    Difference
    0.0%
    Check dated 2026-09-20T19:40:55.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The Record History page appears with a redesigned header and list formatting, while the underlying history data and navigation remain unchanged.
    Difference
    0.0%
    Check dated 2026-09-13T17:34:29.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    No additions or deletions are present in the change history data. The page content remains unchanged from the previous version.
    Difference
    0.0%
    Check dated 2026-09-06T14:41:28.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    The history shows a new site revision from v3.6.5 to v3.6.6. This indicates a deployment with minor fixes or improvements that do not change study information.
    Difference
    0.0%
    Check dated 2026-08-30T08:23:14.000Z thumbnail image

Stay in the know with updates to Safety of Tarlatamab in Adults With SCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety of Tarlatamab in Adults With SCLC Clinical Trial page.